Researchers have made a groundbreaking discovery that could revolutionize the treatment of prostate cancer. By targeting a single enzyme called PI5P4Kα, scientists have found a way to potentially kill prostate cancer cells, offering new hope for patients who face the growing challenge of treatment resistance. The findings, recently published in Science Advances, also suggest that this approach could be effective in treating other cancers, including those affecting the breast, skin, and pancreas. According to Brooke Emerling, Ph.D., an associate professor at Sanford Burnham Prebys and co-senior…